From the operational update:
Novartis intends to initiate a Phase 3 study in non-COVID-19-related ARDS after the anticipated
closing of the license agreement and successful completion and outcome of the current study.
From the operational update:Novartis intends to initiate a Phase...
-
- There are more pages in this discussion • 2,626 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
98.0¢ |
Change
-0.010(1.01%) |
Mkt cap ! $1.118B | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | $1.02 | 97.0¢ | $2.821M | 2.832M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20688 | 97.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 99.0¢ | 35000 | 3 |
View Market Depth
| Last trade - 16.10pm 15/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |